These findings parallel the results of two previous studies in pancreatic cancer (11, 13), indicating that MOR expression in pancreatic ductal adenocarcinoma (PDAC) patients was not associated with worse OS and DFS. The gene discussed is OPRM1; the disease is pancreatic ductal adenocarcinoma.